Heart failure has reached epidemic proportions with the advances in cardiovascular therapies for ischemic heart diseases and the progressive aging of the world population. Efficient pharmacological th

NIAID Data Ecosystem20

Independent predictors for mortality.

心力衰竭治疗

临床预后分析

BackgroundAchieving target doses of angiotensin receptor-neprilysin inhibitor (ARNI) in heart failure with reduced ejection fraction (HFrEF) is often challenging due to concerns related to hypotension

Figshare2025-07-28 更新10

Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial

心力衰竭治疗

β受体药理临床试验

Raw data of the paper: Effects of β 2 -receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial

Zenodo2020-12-21 更新20

Dataset from A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319

心力衰竭治疗

药物安全性评估

The purpose of this study was to evaluate long-term safety and tolerability and to provide post-trial access to sacubitril/valsartan to eligible participants who successfully completed CLCZ696B2319 (P

NIAID Data Ecosystem10

Left ventricular assist device characteristics.

资源简介：

相关数据集